Minerva Neurosciences, Inc. — Director's Dealing 2020

Aug 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2020-06-19

Reporting Person: Smith Devin Whittemore (SVP and General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-19	Employee Stock Option (right to buy)	$7.11	A	153531	Acquired	2029-12-31	Common Stock (153531)	Direct

Footnotes

F1: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter.